Latest News and Press Releases
Want to stay updated on the latest news?
-
New York, NY, and Tel Aviv, ISRAEL, Jan. 05, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company,...
-
In a release issued under the same headline earlier today by Liquid Media Group Ltd. (the “Company,” “Liquid Media” or “Liquid”) (Nasdaq: YVR), please note that the dateline of the release should be...
-
VANCOUVER, British Columba, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Liquid Media Group Ltd. (the “Company,” “Liquid Media” or “Liquid”) (Nasdaq: YVR) is pleased to announce the launch of its first...
-
CHICAGO, Jan. 04, 2022 (GLOBE NEWSWIRE) -- Dresner Partners, a leading FINRA-registered, middle-market investment bank and Mergers Alliance member firm, is pleased to announce that it advised Center...
-
HAUPPAUGE, N.Y., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Orbit International Corp. (OTC PINK:ORBT) today announced that its newly formed subsidiary, Simulator Product Solutions LLC (“SPS”), has completed...
-
PASADENA, Calif., Dec. 20, 2021 (GLOBE NEWSWIRE) -- Guinness Atkinson Asset Management announced today its plans to change the primary listing venue of its SmartETFs Sustainable Energy II ETF (SULR)...
-
MITCHEL FIELD, N.Y., Dec. 09, 2021 (GLOBE NEWSWIRE) -- Frequency Electronics, Inc. (“FEI” or the “Company”) (NASDAQ-FEIM) is reporting revenues for the three- and six-month periods of fiscal 2022,...
-
MITCHEL FIELD, N.Y., Dec. 07, 2021 (GLOBE NEWSWIRE) -- Frequency Electronics, Inc. (NASDAQ: FEIM), will hold a conference call to discuss results for the second quarter of its fiscal year 2022,...
-
Orbit International Corp. Reports Consolidated Bookings of Approximately $2,000,000 in November 2021
HAUPPAUGE, N.Y., Dec. 07, 2021 (GLOBE NEWSWIRE) -- Orbit International Corp. (OTC PINK:ORBT), an electronics manufacturer and software solution provider, today announced that consolidated bookings...
-
New entity poised to accelerate the development of Aerami’s diverse pipeline ofnext-generation inhaled therapies AER-901, Aerami’s proprietary inhaled, nebulized formulation of imatinib, targeted to...